Investors Information
Today's Date: July 31, 2010
Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) is engaged in the research, development, manufacturing and marketing of unique mood-enhancing consumer products. The Company focuses on the development of such products based on naturally occurring compounds. When independent testing validates the safety of the compounds and psychological and physiological testing on consumers confirms the efficacy, the Company seeks patent protection for the use of the technology, develops its own products and / or licenses the proprietary technology to other companies for use in their products.
The Company has previously been granted broad-based patents for its initial compound, Androstadienone, which has been licensed to leading marketers, including Johnson & Johnson, Avon, Schwarkopf & Henkel, Pheromone International and its affiliates.
Click here for detailed information provided by 
Replication or redistribution of Human Pheromone Sciences, Inc. content is expressly prohibited without the prior written consent of Human Pheromone Sciences, Inc. Human Pheromone Sciences, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.